KUALA LUMPUR, Nov 3 (Bernama) -- Nearly 1,000 participants from domestic and international pharmaceutical regulatory agencies, academic societies, and industrial associations, among others, attended the 2nd Boao International Conference on Real World Studies of Medical Products, held in Boao, Hainan recently.
The conference featured a plenary session and eight sub-forums, and encompassed various fields related to international real-world research, and the scientific development of pharmaceutical product regulation.
According to a statement, the topics covered real-world research, drug regulation, pharmaceutical instrument regulation, traditional Chinese medicine regulation, biostatistics, as well as economics.
The conference provided a platform for exchanges and innovations of real-world data research and pharmaceutical product regulatory practices, offering new methods, standards and pathways for advancing the role of real-world research of pharmaceutical products in regulatory decision-making across China and globally.
In the meantime, the Hainan Boao Lecheng International Medical Tourism Pilot Zone (Lecheng Pilot Zone) has been actively collecting real-world evidences and researching to explore how to assist the regulatory decision-making, offering new methods for the reform of the national evaluation system of pharmaceutical products.
Currently, the real-world research in the Lecheng Pilot Zone has stepped on a fast track, largely matching the international advanced level in pharmaceutical technology, instrument and drugs.
It has become a key channel to accelerate the market entry of innovative international pharmaceutical products to China.
To date, the Lecheng Pilot Zone has 26 operational medical institutions as well as established extensive and deep collaborations with over 170 pharmaceutical product enterprises from 20 countries and regions, importing more than 350 critically-needed pharmaceutical products.
-- BERNAMA
Comments